共 78 条
[1]
Gowing L(2009)Buprenorphine for the management of opioid withdrawal Cochrane Database Syst Rev 3 002025-616
[2]
Ali R(2009)Buprenorphine for opioid dependence Expert Rev Neurother 9 609-1200
[3]
White JM(2009)Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment Addiction 104 1193-140
[4]
Ling W(2009)Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients Drug Alcohol Depend 99 132-958
[5]
Bell J(2003)Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone N Engl J Med 349 949-477
[6]
Trinh L(2013)Withdrawal from buprenorphine/naloxone and maintenance with a natural dopaminergic agonist: a cautionary note J Addict Res Ther 23 475-34
[7]
Butler B(2014)A successful treatment of buprenorphine withdrawal with the dopamine receptor agonist pramipexole Am J Addict 47 27-46
[8]
Randall D(2014)Abuse and diversion of buprenorphine sublingual tablets and film J Subst Abuse Treat 141 37-242
[9]
Rubin G(1999)Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers Psychopharmacology 154 230-798
[10]
Jones ES(2001)Effects of buprenorphine/naloxone in opioid-dependent humans Psychopharmacology 20 784-104